replenza supplement review glp-1 therapy support - Daily Nutritional Tablets Replenza™ Nutritional Supplement

22 Preclinical studies have demonstrated the presence of GLP-1 receptors in the lacrimal glands, 13 supporting a direct biological mechanism that may explain the better outcomes observed in our GLP-1 RA group

The evidence base differs significantly between these compounds

Notably, the variants identified by the optimized ONT based system showed 100% concordance with those detected using Illumina-based sequencing, confirming 100% accuracy of the ONT platform in variant detection

F., von Hundelshausen, P., Zernecke, A., Koenen, R

No patients receiving GLP-1 RAs were excluded due to loss of follow-up, while 8 patients (0.2%) who did not receive GLP-1 RAs were excluded for this reason (Supplemental Table 3)